Functionalized Magnetic Particles for Rapid Bacterial Extraction

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional bacterial diagnostics, such as culture-based and microscopy-based tests, are time-consuming, costly, and require specialized facilities and skilled personnel, making them unsuitable for resource-limited settings, and there is a need for rapid, low-cost, and low-tech solutions for bacterial infection diagnosis.

Innovation Solution

Functionalized magnetic particle compositions with a biomimetic binding pair member capable of non-specific binding to biological target analytes, synthesized in a one-pot method, allowing for rapid extraction and detection of bacteria from samples using a simple magnet for separation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If culture-based testing is used for bacterial identification, then diagnostic accuracy is improved, but testing time increases to up to a week

Engineering Contradiction:
Improvediagnostic accuracyVSAvoidtesting time
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The patent applies preliminary action by performing magnetic particle extraction and concentration of bacterial targets from clinical samples before detection. This pre-concentration step enriches the bacterial load in the sample, enabling faster detection methods to achieve sufficient sensitivity without requiring extended culture periods, thus reducing testing time while maintaining diagnostic accuracy

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent uses magnetic particles functionalized with biomimetic binding pair members as an intermediary to capture and concentrate bacterial targets from complex clinical samples. These magnetic particles act as a mediator that binds to bacteria through biomimetic interactions, allowing for rapid separation and concentration that accelerates the diagnostic process while preserving accuracy

Inventive Principle:
Principle #24Intermediary (Mediator)

2Speed

If microscopy-based testing is used for bacterial identification, then testing speed is improved, but device complexity and skill requirements increase

Engineering Contradiction:
Improvetesting speedVSAvoidinstrument complexity
Core Design Contradiction:
SpeedVSDevice complexity

Solution Approach 1:

The patent extracts the bacterial targets from complex clinical samples using magnetic particles functionalized with biomimetic binding pair members. This extraction step isolates the bacteria from interfering substances in the sample matrix, creating a simplified preparation that can be detected with simpler, less expensive instruments while maintaining rapid testing speed

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent uses biomimetic binding pair members that replicate natural biological recognition interactions. These synthetic binders mimic the specificity and affinity of natural receptor-ligand pairs, providing simple yet effective capture mechanisms that do not require complex instrumentation while achieving rapid separation and detection

Inventive Principle:
Principle #26Copying

3Loss of time

If AFB testing is used for Mtb diagnosis, then testing time is reduced to within a day, but measurement precision deteriorates with false positives and negatives

Engineering Contradiction:
Improvetesting timeVSAvoiddiagnostic reliability
Core Design Contradiction:
Loss of timeVSMeasurement precision

Solution Approach 1:

The patent applies local quality by functionalizing magnetic particles with specific biomimetic binding pair members that are tailored to recognize and bind to Mycobacterium tuberculosis. This localized functionalization provides specific binding capability at the particle surface, enabling the test to distinguish Mtb from other acid-fast bacilli and reduce false positives while maintaining rapid one-day turnaround

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent changes the binding parameters by using biomimetic binding pair members with optimized affinity and specificity for Mtb. These engineered binders have enhanced binding characteristics compared to traditional AFB staining methods, allowing for more precise detection that reduces both false positives and false negatives while maintaining rapid testing speed

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method enables rapid, low-cost, and instrument-free bacterial detection in 15-30 minutes, suitable for resource-limited settings, reducing the need for specialized facilities and skilled personnel, and is effective for diagnosing bacterial infections like tuberculosis.

Implementation Method 1

functionalized magnetic particle compositions that can be used for extracting biological target analytes

Methodology Applied
Scientific EffectMagnetism: Magnetism

Implementation Method 2

a (non-specific) binding pair member bound to an external surface of the magnetic particle core, the binding pair member being capable of non-specific binding to one or more biological target analytes

Methodology Applied
Scientific EffectAdsorption: Adsorption

Data Source

PatentUS20250290922A1Functionalized magnetic particle compositions and related methods
Publication Date: 2025.09.18 BOARD OF TRUSTEES OPERATING MICHIGAN STATE UNIV
  • US20250290922A1 patent drawing
  • US20250290922A1 patent drawing
  • US20250290922A1 patent drawing

AI summary

The disclosure relates to functionalized magnetic particle compositions and related methods to extract biological target analytes such as bacteria from samples such as clinical, industrial, or environmental samples. The functionalized magnetic particles can be synthesized in a one-pot method and include a biomimetic binding pair member which permits non-specific binding to one or more biological target analytes, such as when using the functionalized magnetic particles to extract pathogens or other analytes from a sample matrix. The functionalized magnetic particle composition generally includes a magnetic particle core, and a binding pair member bound to an external surface of the magnetic particle core, where the binding pair member is capable of non-specific binding to a plurality of biological target analytes.